Pomalidomide 4'-PEG2-acid (Synonyms: Pomalidomide 4'-PEG2-acid) |
| Katalog-Nr.GC50690 |
Pomalidomide 4'-PEG2-SÄure (Pomalidomide 4'-PEG2-SÄure) ist ein synthetisiertes E3-Ligase-Ligand-Linker-Konjugat, das den Pomalidomid-basierten Cereblon-Liganden und den 2-Einheiten-PEG-Linker enthÄlt, die in der PROTAC-Technologie verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2140807-17-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal acid ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D. PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Average Rating: 5 (Based on Reviews and 10 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *